vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
You can purchase shares of vTv Therapeutics (NASDAQ:VTVT) through any online brokerage.
Other companies in vTv Therapeutics’s space includes: OncoCyte (NASDAQ:OCX), Barinthus Biotherapeutics (NASDAQ:BRNS), Precision BioSciences (NASDAQ:DTIL), Lisata Therapeutics (NASDAQ:LSTA) and OKYO Pharma (NASDAQ:OKYO).
vTv Therapeutics has a consensus price target of $12.00.
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $13.81 last updated January 21, 2025 at 9:13 AM EST.
There are no upcoming dividends for vTv Therapeutics.
vTv Therapeutics’s Q4 earnings are confirmed for Wednesday, March 12, 2025.
There is no upcoming split for vTv Therapeutics.
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.